financetom
Business
financetom
/
Business
/
Pembina Pipeline Up 0.2% As Meets Q1 Earnings Forecast; Raises Dividend
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Pembina Pipeline Up 0.2% As Meets Q1 Earnings Forecast; Raises Dividend
May 26, 2025 4:43 AM

05:35 PM EDT, 05/08/2025 (MT Newswires) -- Pembina Pipeline ( PBA ) was up 0.2% in US after hours as it met first-quarter earnings expectations and raised its dividend.

The oil and gas infrastructure and processing company reported first-quarter earnings of $502 million, adjusted EBITDA of $1,167 million, and adjusted cash flow from operating activities of $777 million or $1.34 per share), which compared to $1.42 in the year earlier period.

Earnings per share were $0.80 versus $0.74 a year ago and meeting the FactSet forecast.

The board of directors declared a dividend for the second quarter of 2025 of $0.71 per share, a 3% increase, to be paid on June 30 to shareholders of record on June 16.

On guidance, the company is currently trending towards the midpoint of its 2025 adjusted EBITDA guidance range of $4.2 billion to $4.5 billion.

The company's shares were last seen up US$0.09 to US$39.50 after hours. They closed up $0.31 to $54.86 on the Toronto Stock Exchange.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
What's Going On With Rumble Stock?
What's Going On With Rumble Stock?
Mar 26, 2024
Rumble Inc. ( RUM ) shares are trading higher Tuesday, possibly in sympathy with Trump Media & Technology Group Corp. after the company debuted on the Nasdaq Tuesday.  What To Know: Trump Media & Technology Group debuted on the Nasdaq Tuesday. Rumble CEO Chris Pavlovski congratulated the company and its CEO on the social media platform, X.  A big congrats...
Syndax Pharmaceuticals Says FDA Grants Priority Review to New Drug Application for Acute Leukemia Treatment
Syndax Pharmaceuticals Says FDA Grants Priority Review to New Drug Application for Acute Leukemia Treatment
Mar 26, 2024
04:49 PM EDT, 03/26/2024 (MT Newswires) -- Syndax Pharmaceuticals ( SNDX ) said late Tuesday the US Food and Drug Administration has granted priority review for the company's new drug application for revumenib to treat relapsed or refractory acute leukemia, a type of cancer. The company said the filing was assigned a prescription drug user fee act target action date...
BRIEF-FCPT Announces Acquisition Of A Heartland Dental Property For $2.0 Million
BRIEF-FCPT Announces Acquisition Of A Heartland Dental Property For $2.0 Million
Mar 26, 2024
March 26 (Reuters) - Four Corners Property Trust Inc ( FCPT ) : * FCPT ANNOUNCES ACQUISITION OF A HEARTLAND DENTAL PROPERTY FOR $2.0 MILLION Source text for Eikon: Further company coverage: ...
Looking At Applied Mat's Recent Unusual Options Activity
Looking At Applied Mat's Recent Unusual Options Activity
Mar 26, 2024
Whales with a lot of money to spend have taken a noticeably bullish stance on Applied Mat. Looking at options history for Applied Mat we detected 21 trades. If we consider the specifics of each trade, it is accurate to state that 52% of the investors opened trades with bullish expectations and 47% with bearish. From the overall spotted trades,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved